Visano Theranostics
1 known investors
Visano Theranostics develops PSMA-targeted nanobubble contrast agents that add real-time molecular imaging to standard ultrasound workflows for the diagnosis and treatment of prostate cancer. The company licensed nanobubble technologies from Case Western Reserve University and is focused on precision oncology for prostate cancer.
BiotechHealthtechMedical Devices
Founders & leadership
JP
James P. BasilionInventor, Co-founder
AA
Agata A. ExnerInventor, Co-founder
MJ
Michael J. HaagCo-founder & Chief Executive Officer
Investors · 1
Frequently asked questions
- What does Visano Theranostics do?
- Visano Theranostics develops PSMA-targeted nanobubble contrast agents that add real-time molecular imaging to standard ultrasound workflows for the diagnosis and treatment of prostate cancer. The company licensed nanobubble technologies from Case Western Reserve University and is focused on precision oncology for prostate cancer.
- Who founded Visano Theranostics?
- Visano Theranostics was founded by James P. Basilion, Agata A. Exner, Michael J. Haag.
- Who are Visano Theranostics's investors?
- Visano Theranostics's investors include JumpStart Equity.